Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies

Documenti analoghi

• Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
  di: Vijay, Suresh, et al.
  Pubblicazione: (2021)
• Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
  di: Malinová, Vĕra, et al.
  Pubblicazione: (2020)
• Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study
  di: Jones, Simon A., et al.
  Pubblicazione: (2017)
• The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency
  di: Erwin, Angelika L.
  Pubblicazione: (2017)
• Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa
  di: Su, Kim, et al.
  Pubblicazione: (2016)